NYSE:THC - Tenet Healthcare Stock Price Target and Predictions

Target and Analyst Ratings
Price Target History
Upgrades and Downgrades
About
FAQ

Consensus Rating: Buy
Consensus Price Target: $55.19
Forecasted Upside: -19.34 %
Number of Analysts: 12
Breakdown:
1 Sell Ratings
2 Hold Ratings
9 Buy Ratings
0 Strong Buy Ratings

^$68.42 As of 06/22/2021 01:00 AM ET

▼ -0.16 (-0.23%)

1 month | 3 months | 12 months

Get New Tenet Healthcare Analyst Ratings Delivered To Your Inbox

Sign-up to receive the latest news and ratings for THC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for THC

^$55.19

▼ -19.34% Downside Potential

This price target is based on 12 analysts offering 12 month price targets for Tenet Healthcare in the last 3 months. The average price target is $55.19, with a high forecast of $71.00 and a low forecast of $20.00. The average price target represents a -19.34% upside from the last price of $68.42.

Current Consensus is Buy

The current consensus among 12 investment analysts is to buy stock in Tenet Healthcare. This rating has held steady since August 2019, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations Description Skip Past Price Target Consensus Chart

0 strong buy ratings
8 buy ratings
3 hold ratings
1 sell ratings

Ratings as of

12/30/2019

0 strong buy ratings
6 buy ratings
2 hold ratings
1 sell ratings

Ratings as of

3/29/2020

0 strong buy ratings
7 buy ratings
3 hold ratings
1 sell ratings

Ratings as of

6/27/2020

0 strong buy ratings
6 buy ratings
3 hold ratings
1 sell ratings

Ratings as of

9/25/2020

0 strong buy ratings
7 buy ratings
4 hold ratings
1 sell ratings

Ratings as of

12/24/2020

0 strong buy ratings
9 buy ratings
4 hold ratings
1 sell ratings

Ratings as of

3/24/2021

0 strong buy ratings
9 buy ratings
2 hold ratings
1 sell ratings

Ratings as of

5/23/2021

0 strong buy ratings
9 buy ratings
2 hold ratings
1 sell ratings

Ratings as of

6/22/2021

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
6/18/2021	Jefferies Financial Group	Reiterated Rating	Buy		High
5/5/2021	Mizuho	Boost Price Target	Buy	$55.00 ➝ $70.00	Low
5/3/2021	The Goldman Sachs Group	Initiated Coverage	Buy		High
4/23/2021	Barclays	Boost Price Target		$55.00 ➝ $62.00	High
4/22/2021	Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell	Boost Price Target		$58.00 ➝ $65.00	Medium
4/22/2021	Truist Securities	Boost Price Target		$56.00 ➝ $60.00	Medium
4/22/2021	Truist	Boost Price Target		$56.00 ➝ $60.00	High
4/22/2021	Citigroup	Boost Price Target		$58.00 ➝ $65.00	High
4/22/2021	Credit Suisse Group	Boost Price Target	Outperform	$58.00 ➝ $71.00	High
4/22/2021	Royal Bank of Canada	Boost Price Target	Outperform	$57.00 ➝ $66.00	High
4/9/2021	Mizuho	Boost Price Target	Buy	$48.00 ➝ $55.00	Medium
2/11/2021	Citigroup	Boost Price Target		$50.00 ➝ $58.00	Low
2/11/2021	Credit Suisse Group	Boost Price Target	Outperform	$52.00 ➝ $58.00	Low
1/21/2021	UBS Group	Boost Price Target	Positive ➝ Buy	$37.00 ➝ $60.00	High
1/14/2021	Raymond James	Boost Price Target	Outperform	$55.00 ➝ $60.00	High
1/8/2021	Jefferies Financial Group	Upgrade	Hold ➝ Buy	$27.00 ➝ $60.00	Low
1/5/2021	Bank of America	Upgrade	Neutral ➝ Buy	$45.00 ➝ $50.00	N/A
12/18/2020	Mizuho	Boost Price Target	Buy	$32.00 ➝ $48.00	Medium
12/15/2020	Deutsche Bank Aktiengesellschaft	Upgrade	Hold ➝ Buy		Medium
12/11/2020	Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell	Boost Price Target		$33.00 ➝ $50.00	Medium
12/11/2020	Smith Barney Citigroup	Boost Price Target		$33.00 ➝ $50.00	High
12/11/2020	Credit Suisse Group	Boost Price Target	Outperform	$39.00 ➝ $48.00	Medium
12/11/2020	Barclays	Boost Price Target	Equal Weight	$28.00 ➝ $46.00	High
11/11/2020	Piper Sandler	Boost Price Target	Neutral	$31.00 ➝ $36.00	High
11/9/2020	Mizuho	Boost Price Target	Buy	$30.00 ➝ $32.00	High
10/22/2020	Raymond James	Boost Price Target	Outperform	$40.00 ➝ $43.00	High
9/21/2020	JPMorgan Chase & Co.	Downgrade	Neutral ➝ Underweight	$28.00 ➝ $20.00	High
9/4/2020	Royal Bank of Canada	Boost Price Target		$30.00 ➝ $35.00	Low
8/14/2020	Truist	Boost Price Target		$21.00 ➝ $30.00	Medium
8/10/2020	UBS Group	Boost Price Target	Buy	$30.00 ➝ $35.00	Low
8/5/2020	Deutsche Bank Aktiengesellschaft	Boost Price Target	Hold	$25.00 ➝ $28.00	High
8/4/2020	Credit Suisse Group	Reiterated Rating	Buy		High
6/11/2020	UBS Group	Lower Price Target	Buy	$32.00 ➝ $30.00	High
5/29/2020	Mizuho	Lower Price Target	Buy	$32.00 ➝ $30.00	High
5/21/2020	SunTrust Banks	Boost Price Target	Hold	$22.00 ➝ $25.00	Medium
5/20/2020	Citigroup	Lower Price Target	Buy	$35.00 ➝ $27.00	High
5/14/2020	UBS Group	Lower Price Target	Buy	$49.00 ➝ $32.00	High
5/11/2020	Barclays	Boost Price Target	Equal Weight	$19.00 ➝ $22.00	Low
5/6/2020	Credit Suisse Group	Reiterated Rating	Buy	$33.00	Low
5/6/2020	Wells Fargo & Company	Lower Price Target	Equal Weight	$40.00 ➝ $32.00	Low
5/6/2020	Deutsche Bank Aktiengesellschaft	Lower Price Target	Hold	$31.00 ➝ $25.00	High
4/13/2020	SunTrust Banks	Boost Price Target	Hold	$18.00 ➝ $22.00	Low
4/13/2020	Royal Bank of Canada	Reiterated Rating	Buy	$26.00	Medium
4/3/2020	SunTrust Banks	Lower Price Target	Hold	$42.00 ➝ $18.00	High
3/25/2020	Barclays	Reiterated Rating	Hold	$19.00	High
3/11/2020	Royal Bank of Canada	Upgrade	Sector Perform ➝ Outperform	$32.00 ➝ $39.00	High
2/26/2020	JPMorgan Chase & Co.	Upgrade	Underweight ➝ Neutral	$31.00 ➝ $32.00	High
1/3/2020	Deutsche Bank Aktiengesellschaft	Initiated Coverage	Hold	$20.00	Low
12/20/2019	JPMorgan Chase & Co.	Boost Price Target	Underweight	$23.00 ➝ $31.00	Medium
12/18/2019	SunTrust Banks	Boost Price Target	Hold	$31.00 ➝ $42.00	Medium
12/9/2019	UBS Group	Upgrade	Neutral ➝ Buy	$24.00 ➝ $53.00	High
11/7/2019	Mizuho	Reiterated Rating	Buy		Low
11/6/2019	Mizuho	Boost Price Target		$30.00 ➝ $33.00	Low
11/6/2019	SunTrust Banks	Boost Price Target	Hold	$24.00 ➝ $31.00	High
11/6/2019	Credit Suisse Group	Upgrade	Neutral ➝ Outperform	$25.00 ➝ $36.00	High
8/14/2019	The Goldman Sachs Group	Initiated Coverage	Neutral ➝ Neutral	$28.00 ➝ $28.00	High
8/11/2019	Royal Bank of Canada	Reiterated Rating	Hold	$26.00	Medium
8/7/2019	SunTrust Banks	Set Price Target	Hold	$24.00	Low
5/1/2019	SunTrust Banks	Lower Price Target	Hold	$27.00	High
4/17/2019	Barclays	Set Price Target	Hold	$24.00	Medium
2/27/2019	Raymond James	Boost Price Target		$37.00 ➝ $47.00	Medium
2/27/2019	Citigroup	Boost Price Target	Buy ➝ Buy	$35.00 ➝ $37.00	High
2/26/2019	Bank of America	Reiterated Rating	Neutral ➝ Neutral	$21.00 ➝ $30.00	High
1/28/2019	Mizuho	Reiterated Rating	Buy	$28.00	Low
1/14/2019	Stephens	Initiated Coverage	Equal ➝ Equal Weight	$23.00	Medium
1/6/2019	Barclays	Reiterated Rating	Hold	$20.00	High
1/3/2019	Deutsche Bank Aktiengesellschaft	Initiated Coverage	Hold ➝ Hold	$20.00	Low
12/17/2018	Robert W. Baird	Downgrade	Outperform ➝ Neutral		High
12/3/2018	Raymond James	Reiterated Rating	Buy	$37.00	High
11/15/2018	UBS Group	Initiated Coverage	Neutral ➝ Neutral	$26.00	Low
11/7/2018	Robert W. Baird	Reiterated Rating	Buy	$35.00	High
11/7/2018	Barclays	Reiterated Rating	Hold	$27.00	High
8/14/2018	Barclays	Initiated Coverage	Equal Weight	$35.00	Low
8/10/2018	JPMorgan Chase & Co.	Boost Price Target	Underweight ➝ Underweight	$22.00 ➝ $28.00	Low
8/8/2018	Piper Jaffray Companies	Reiterated Rating	Hold	$34.00	Medium
8/8/2018	SunTrust Banks	Reiterated Rating	Hold	$35.00	Medium
8/7/2018	Mizuho	Set Price Target	Buy	$36.00	Medium
7/23/2018	Citigroup	Boost Price Target	Buy ➝ Buy	$37.00 ➝ $44.00	High
6/29/2018	Jefferies Financial Group	Downgrade	Buy ➝ Hold	$28.00 ➝ $38.00	Medium
5/9/2018	Mizuho	Reiterated Rating	Buy	$35.00	Medium
5/8/2018	Citigroup	Boost Price Target	Buy ➝ Buy	$27.00 ➝ $37.00	Low
5/4/2018	Credit Suisse Group	Boost Price Target	Neutral ➝ Neutral	$27.00 ➝ $33.00	Low
5/2/2018	Morgan Stanley	Boost Price Target	Underweight ➝ Underweight	$16.00 ➝ $24.00	High
5/2/2018	SVB Leerink	Boost Price Target	Outperform	$30.00 ➝ $40.00	High
4/17/2018	SunTrust Banks	Reiterated Rating	Hold	$27.00	Low
3/22/2018	Mizuho	Reiterated Rating	Buy	$29.00	High
3/5/2018	JPMorgan Chase & Co.	Boost Price Target	Underweight ➝ Underweight	$15.00 ➝ $18.00	Low
3/1/2018	Piper Jaffray Companies	Reiterated Rating	Hold	$21.00	High
3/1/2018	SunTrust Banks	Reiterated Rating	Hold		High
3/1/2018	Citigroup	Boost Price Target	Buy ➝ Buy	$19.00 ➝ $27.00	Low
2/28/2018	Morgan Stanley	Boost Price Target	Underweight ➝ Underweight	$15.00 ➝ $16.00	Medium
2/28/2018	Wells Fargo & Company	Boost Price Target	Market Perform ➝ Market Perform	$20.00 ➝ $22.00	High
2/28/2018	Raymond James	Upgrade	Market Perform ➝ Outperform	$30.00	High
2/27/2018	Jefferies Financial Group	Set Price Target	Buy	$23.00	Low
1/30/2018	Wells Fargo & Company	Initiated Coverage	Market Perform ➝ Market Perform	$20.00	High
1/3/2018	The Goldman Sachs Group	Initiated Coverage	Neutral ➝ Neutral	$15.00	High
12/20/2017	SVB Leerink	Reiterated Rating	Buy	$27.00	Low
12/20/2017	Morgan Stanley	Downgrade	Equal Weight ➝ Underweight	$14.00	Medium
12/19/2017	Mizuho	Boost Price Target	Neutral	$13.00 ➝ $15.00	High
12/14/2017	JPMorgan Chase & Co.	Downgrade	Neutral ➝ Underweight	$15.00	Medium
12/12/2017	Citigroup	Upgrade	Neutral ➝ Buy		High
11/21/2017	William Blair	Reiterated Rating	Market Perform		N/A
11/13/2017	Royal Bank of Canada	Lower Price Target	Sector Perform	$19.00 ➝ $17.00	N/A
11/10/2017	Mizuho	Reiterated Rating	Neutral ➝ Hold		N/A
11/9/2017	Morgan Stanley	Lower Price Target	Equal Weight	$15.00 ➝ $14.00	N/A
11/8/2017	SVB Leerink	Reiterated Rating	Outperform	$30.00 ➝ $25.00	N/A
11/2/2017	Credit Suisse Group	Initiated Coverage	Neutral	$15.00	N/A
10/30/2017	Jefferies Financial Group	Set Price Target	Buy	$24.00 ➝ $20.00	N/A
10/15/2017	SunTrust Banks	Set Price Target	Hold	$15.00	N/A
9/28/2017	Robert W. Baird	Reiterated Rating	Buy	$23.00	High
9/25/2017	Royal Bank of Canada	Reiterated Rating	Hold	$19.00	High
9/21/2017	Jefferies Financial Group	Reiterated Rating	Buy	$24.00	Low
9/14/2017	Mizuho	Reiterated Rating	Neutral	$14.00	Medium
9/14/2017	Citigroup	Reiterated Rating	Hold	$16.00	Medium
9/1/2017	Deutsche Bank Aktiengesellschaft	Reiterated Rating	Buy	$24.00	Low
8/24/2017	Robert W. Baird	Reiterated Rating	Buy	$23.00	Low
8/24/2017	Royal Bank of Canada	Reiterated Rating	Hold	$25.00	Low
8/20/2017	Mizuho	Reiterated Rating	Neutral	$14.00	High
8/20/2017	SVB Leerink	Reiterated Rating	Outperform	$23.00 ➝ $30.00	High
8/10/2017	Deutsche Bank Aktiengesellschaft	Reiterated Rating	Buy	$28.00 ➝ $24.00	Low
8/10/2017	Citigroup	Reiterated Rating	Neutral	$20.00 ➝ $16.00	Medium
8/10/2017	Robert W. Baird	Reiterated Rating	Outperform	$23.00	Medium
8/9/2017	Credit Suisse Group	Lower Price Target	Neutral	$20.00 ➝ $17.00	Low
8/8/2017	Jefferies Financial Group	Reiterated Rating	Buy ➝ Buy	$26.00 ➝ $24.00	High
7/18/2017	Royal Bank of Canada	Reiterated Rating	Hold	$25.00	Medium
6/6/2017	SVB Leerink	Upgrade	Market Perform ➝ Outperform	$27.00	Medium
6/6/2017	Morgan Stanley	Initiated Coverage	Equal ➝ Equal Weight	$19.00	High
6/6/2017	Wells Fargo & Company	Upgrade	Market Perform ➝ Outperform	$22.00	Low
5/15/2017	Credit Suisse Group	Boost Price Target	Neutral	$18.00 ➝ $20.00	Medium
5/5/2017	Credit Suisse Group	Boost Price Target	Neutral	$18.00 ➝ $20.00	Low
4/29/2017	Jefferies Financial Group	Reiterated Rating	Buy	$28.00 ➝ $26.00	Low
4/23/2017	Mizuho	Reiterated Rating	Neutral	$18.00	Low
4/13/2017	Jefferies Financial Group	Reiterated Rating	Buy	$28.00	Low
4/4/2017	Deutsche Bank Aktiengesellschaft	Initiated Coverage	Buy	$28.00	High
3/27/2017	Mizuho	Lower Price Target	Neutral	$22.50 ➝ $18.00	High
3/6/2017	Citigroup	Lower Price Target	Neutral	$22.00 ➝ $20.00	N/A
3/3/2017	Royal Bank of Canada	Reiterated Rating	Hold	$25.00	N/A
2/24/2017	Mizuho	Upgrade	Underperform ➝ Neutral	$13.00 ➝ $22.80	N/A
2/6/2017	Jefferies Financial Group	Lower Price Target	Buy	$36.00 ➝ $28.00	N/A
1/24/2017	SVB Leerink	Reiterated Rating	Market Perform	$22.00	N/A
1/11/2017	UBS Group	Reiterated Rating	Buy	$26.00 ➝ $24.00	N/A
1/3/2017	Piper Jaffray Companies	Initiated Coverage	Neutral	$16.00	N/A
11/22/2016	Mizuho	Downgrade	Neutral ➝ Underperform	$13.00	N/A
11/10/2016	Raymond James	Downgrade	Outperform ➝ Market Perform		N/A
11/10/2016	UBS Group	Downgrade	Outperform ➝ Market Perform		N/A
11/9/2016	Bank of America	Downgrade	Buy ➝ Neutral	$32.00 ➝ $25.00	N/A
10/25/2016	Wolfe Research	Initiated Coverage	Market Perform		N/A
10/5/2016	Mizuho	Lower Price Target	Neutral	$28.00 ➝ $22.00	N/A
9/4/2016	SVB Leerink	Reiterated Rating	Market Perform	$30.00 ➝ $28.00	N/A
8/22/2016	UBS Group	Reiterated Rating	Buy		N/A
8/19/2016	Barclays	Reiterated Rating	Buy	$39.00	N/A
8/4/2016	Citigroup	Lower Price Target	Neutral	$36.00 ➝ $31.00	N/A
8/2/2016	Morgan Stanley	Reiterated Rating	Hold	$38.00	N/A
8/2/2016	Mizuho	Reiterated Rating	Neutral	$33.00 ➝ $28.00	N/A
7/11/2016	Jefferies Financial Group	Reiterated Rating	Buy		N/A
6/28/2016	Credit Suisse Group	Reiterated Rating	Hold		N/A

(Data available from 6/23/2016 forward)

Tenet Healthcare Corporation operates as a diversified healthcare services company. The company operates in three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; quaternary care services in heart and kidney transplants; and limb-salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging, and telemedicine access services. In addition, it operates ambulatory surgery and urgent care centers, imaging centers, surgical hospitals, off-campus emergency departments, and micro-hospitals; and offers healthcare business process services in the areas of hospital and physician revenue cycle management, patient communications and engagement support, and value-based care solutions to hospitals, health systems, physician practices, employers, and other customers. As of December 31, 2020, the company operated 65 hospitals; and approximately 550 other healthcare facilities, including surgical hospitals, ambulatory surgery centers, urgent care and imaging centers, and other care sites and clinics. Tenet Healthcare Corporation was incorporated in 1975 and is headquartered in Dallas, Texas.

Today's Range

Now: $68.42

$67.82

$68.72

50 Day Range

MA: $63.07

$52.02

$68.78

52 Week Range

Now: $68.42

$16.21

$70.75

Volume

719,264 shs

Average Volume

1,029,577 shs

Market Capitalization

$7.31 billion

P/E Ratio

18.34

Dividend Yield

N/A

Beta

2.62

Frequently Asked Questions

What sell-side analysts currently cover shares of Tenet Healthcare?

The following Wall Street research analysts have issued stock ratings on Tenet Healthcare in the last year: Bank of America Co., Barclays PLC, Citigroup Inc., Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell, Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, Jefferies Financial Group Inc., JPMorgan Chase & Co., Mizuho, Piper Sandler, Raymond James, Royal Bank of Canada, Smith Barney Citigroup, The Goldman Sachs Group, Inc., TheStreet, Truist, Truist Securities, UBS Group AG, and Zacks Investment Research.
View the latest analyst ratings for THC.

What is the current price target for Tenet Healthcare?

16 Wall Street analysts have set twelve-month price targets for Tenet Healthcare in the last year. Their average twelve-month price target is $55.19, suggesting a possible downside of 19.3%. Credit Suisse Group AG has the highest price target set, predicting THC will reach $71.00 in the next twelve months. JPMorgan Chase & Co. has the lowest price target set, forecasting a price of $20.00 for Tenet Healthcare in the next year.
View the latest price targets for THC.

What is the current consensus analyst rating for Tenet Healthcare?

Tenet Healthcare currently has 1 sell rating, 2 hold ratings and 9 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe THC will outperform the market and that investors should add to their positions of Tenet Healthcare.
View the latest ratings for THC.

What other companies compete with Tenet Healthcare?

Other companies that are similar to Tenet Healthcare include HCA Healthcare, Alcon, Universal Health Services, Encompass Health, Acadia Healthcare, Select Medical, Petco Health and Wellness, The Ensign Group, Community Health Systems, Brookdale Senior Living, U.S. Physical Therapy, National HealthCare, Five Star Senior Living and Capital Senior Living.

How do I contact Tenet Healthcare's investor relations team?

Tenet Healthcare's physical mailing address is 14201 Dallas Parkway, DALLAS TX, 75254. The company's listed phone number is 469-893-2200 and its investor relations email address is [email protected] The official website for Tenet Healthcare is www.tenethealth.com.